Liontrust Macro UK Growth I Acc (FUND:B7MVBY0) - Overview

Fund Report

Liontrust Macro UK Growth Fund I Acc

Key Stats
Morningstar® CategoryUK Large-Cap Growth Equity
Manager NameStephen Bailey
Inception Date08/10/2012
NAV 09/12/2016GBX 294.91
Day Change0.50%
12 Month Yield3.50%
ISINGB00B7MVBY07
SEDOLB7MVBY0
Dividend FrequencySemi-Annually
Net Assets (mil) 30/11/201644.27 GBP
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time11:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Fund Ongoing Charge0.97%
AMC0.75%
Fund Rebate-

Morningstar Rating™

StarRatingValueLabel_2

Morningstar Sustainability Rating

High

High


Sustainability Rating as of 31/10/2016

Benchmarks

Fund Benchmark

FTSE AllSh TR GBP

Morningstar® Benchmark

MSCI UK Growth NR GBP

Morningstar Analyst Rating™ *

Neutral

Growth Of 10,000 (GBP) 30/11/2016

How has this security performed
20122013201420152016
Fund-30.683.766.20-3.09
Category-24.372.486.535.14
Benchmark-21.161.499.195.22
  • Fund: Liontrust Macro UK Growth Fund I Acc
  • Category: UK Large-Cap Growth Equity
  • Benchmark: MSCI UK Growth NR GBP
Trailing Returns % (GBP) 09/12/2016
FundCatBmark
YTD-2.595.995.94
3 Years Annualised3.466.476.71
5 Years Annualised---
10 Years Annualised---

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The investment objective of the Liontrust Macro UK Growth Fund is to provide Unitholders with a combination of long term capital growth and a measure of income derived from a diversified portfolio of predominantly UK equities and bonds.

Portfolio Profile30/11/2016

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
GlaxoSmithKline PLC Healthcare4.69
BT Group PLC Communication Services4.52
IncreaseVirgin Money Holdings (UK) PLC Financial Services3.93
Pfizer Inc Healthcare3.86
Merck & Co Inc Healthcare3.46
Asset Allocation %
LongShortNet
Stocks98.870.0098.87
Bonds0.000.000.00
Cash1.130.001.13
Other0.000.000.00
Top Stock Regions
Region%
United Kingdom82.42
United States17.58
Japan0.00
Australasia0.00
Asia - Developed0.00
Top Stock Sectors
Stock Sector%
Financial Services25.47
Healthcare22.24
Communication Services14.16
Consumer Cyclical13.53
Basic Materials7.49
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.